A detailed history of Mastrapasqua Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Mastrapasqua Asset Management Inc holds 56,828 shares of AMGN stock, worth $18.1 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
56,828
Previous 57,225 0.69%
Holding current value
$18.1 Million
Previous $12.7 Million 20.21%
% of portfolio
1.79%
Previous 1.43%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

SELL
$218.65 - $271.46 $86,804 - $107,769
-397 Reduced 0.69%
56,828 $15.3 Million
Q2 2023

Aug 02, 2023

BUY
$214.27 - $253.37 $229,054 - $270,852
1,069 Added 1.9%
57,225 $12.7 Million
Q1 2023

Apr 27, 2023

SELL
$225.79 - $275.2 $113,120 - $137,875
-501 Reduced 0.88%
56,156 $13.6 Million
Q4 2022

Feb 01, 2023

SELL
$229.03 - $291.01 $125,737 - $159,764
-549 Reduced 0.96%
56,657 $14.9 Million
Q3 2022

Oct 27, 2022

BUY
$224.46 - $253.15 $276,085 - $311,374
1,230 Added 2.2%
57,206 $12.9 Million
Q2 2022

Jul 26, 2022

SELL
$230.71 - $256.74 $140,963 - $156,868
-611 Reduced 1.08%
55,976 $13.6 Million
Q1 2022

Apr 21, 2022

SELL
$219.27 - $242.57 $759,770 - $840,505
-3,465 Reduced 5.77%
56,587 $13.7 Million
Q4 2021

Jan 21, 2022

BUY
$198.88 - $227.6 $64,238 - $73,514
323 Added 0.54%
60,052 $13.5 Million
Q3 2021

Nov 01, 2021

SELL
$212.27 - $248.7 $324,773 - $380,511
-1,530 Reduced 2.5%
59,729 $12.7 Million
Q2 2021

Aug 06, 2021

BUY
$233.58 - $259.14 $70,074 - $77,742
300 Added 0.49%
61,259 $14.9 Million
Q1 2021

May 03, 2021

BUY
$221.91 - $258.6 $594,940 - $693,306
2,681 Added 4.6%
60,959 $15.2 Million
Q4 2020

Feb 02, 2021

SELL
$216.38 - $257.67 $504,165 - $600,371
-2,330 Reduced 3.84%
58,278 $13.4 Million
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $224,090 - $249,207
955 Added 1.6%
60,608 $15.4 Million
Q2 2020

Jul 29, 2020

SELL
$197.81 - $242.74 $98,905 - $121,370
-500 Reduced 0.83%
59,653 $14.1 Million
Q1 2020

May 08, 2020

BUY
$182.24 - $241.7 $244,930 - $324,844
1,344 Added 2.29%
60,153 $12.2 Million
Q4 2019

Feb 05, 2020

BUY
$189.21 - $243.2 $4,162 - $5,350
22 Added 0.04%
58,809 $14.2 Million
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $98,720 - $118,287
-567 Reduced 0.96%
58,787 $11.4 Million
Q2 2019

Aug 12, 2019

SELL
$166.7 - $195.41 $142,528 - $167,075
-855 Reduced 1.42%
59,354 $10.9 Million
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $2,893 - $3,262
-16 Reduced 0.03%
60,209 $11.4 Million
Q4 2018

Feb 12, 2019

SELL
$178.4 - $208.25 $105,791 - $123,492
-593 Reduced 0.98%
60,225 $11.7 Million
Q3 2018

Nov 15, 2018

BUY
$185.29 - $208.89 $339,080 - $382,268
1,830 Added 3.1%
60,818 $12.6 Million
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $103,117 - $115,822
-621 Reduced 1.04%
58,988 $10.9 Million
Q1 2018

Sep 24, 2018

SELL
$169.43 - $198.0 $28,972 - $33,858
-171 Reduced 0.29%
59,609 $10.2 Million
Q4 2017

Feb 09, 2018

SELL
$168.79 - $188.59 $212,675 - $237,623
-1,260 Reduced 2.06%
59,780 $10.4 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $130,820 - $149,362
782 Added 1.3%
61,040 $11.4 Million
Q2 2017

Aug 07, 2017

BUY
N/A
60,258
60,258 $10.4 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mastrapasqua Asset Management Inc Portfolio

Follow Mastrapasqua Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mastrapasqua Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mastrapasqua Asset Management Inc with notifications on news.